Laties AM - Search Results

1

No clinically important effects on intraocular pressure after short-term administration of sildenafil citrate (Viagra).

Yajima T, Yajima Y, Koppiker N, Grunwald JE, Laties AM. Yajima T, et al. Among authors: laties am. Am J Ophthalmol. 2000 May;129(5):675-6. doi: 10.1016/s0002-9394(00)00375-5. Am J Ophthalmol. 2000. PMID: 10844068 Clinical Trial.

2

A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration.

Birch DG, Toler SM, Swanson WH, Fish GE, Laties AM. Birch DG, et al. Among authors: laties am. Am J Ophthalmol. 2002 May;133(5):665-72. doi: 10.1016/s0002-9394(02)01338-7. Am J Ophthalmol. 2002. PMID: 11992864 Clinical Trial.

3

A 4-year update on the safety of sildenafil citrate (Viagra).

Padma-nathan H, Eardley I, Kloner RA, Laties AM, Montorsi F. Padma-nathan H, et al. Among authors: laties am. Urology. 2002 Sep;60(2 Suppl 2):67-90. doi: 10.1016/s0090-4295(02)01752-1. Urology. 2002. PMID: 12414335 Review.

4

Ocular safety of Viagra, (sildenafil citrate).

Laties AM, Fraunfelder FT. Laties AM, et al. Trans Am Ophthalmol Soc. 1999;97:115-25; discussion 125-8. Trans Am Ophthalmol Soc. 1999. PMID: 10703120 Free PMC article.

5

Viagra (sildenafil citrate) and ophthalmology.

Laties A, Zrenner E. Laties A, et al. Prog Retin Eye Res. 2002 Sep;21(5):485-506. doi: 10.1016/s1350-9462(02)00013-7. Prog Retin Eye Res. 2002. PMID: 12207947 Review.

6

Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction.

Laties A, Sharlip I. Laties A, et al. J Sex Med. 2006 Jan;3(1):12-27. doi: 10.1111/j.1743-6109.2005.00194.x. J Sex Med. 2006. PMID: 16409214 Review.

7

Association between intraocular pressure and budesonide inhalation therapy in asthmatic patients.

Duh MS, Walker AM, Lindmark B, Laties AM. Duh MS, et al. Among authors: laties am. Ann Allergy Asthma Immunol. 2000 Nov;85(5):356-61. doi: 10.1016/S1081-1206(10)62545-8. Ann Allergy Asthma Immunol. 2000. PMID: 11101175 Free article. Clinical Trial.

8

Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Wirostko BM, Tressler C, Hwang LJ, Burgess G, Laties AM. Wirostko BM, et al. Among authors: laties am. BMJ. 2012 Feb 21;344:e554. doi: 10.1136/bmj.e554. BMJ. 2012. PMID: 22354598 Free PMC article. Clinical Trial.

9

Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Laties AM. Laties AM. Drug Saf. 2009;32(1):1-18. doi: 10.2165/00002018-200932010-00001. Drug Saf. 2009. PMID: 19132801 Review.

10

Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors.

Campbell UB, Walker AM, Gaffney M, Petronis KR, Creanga D, Quinn S, Klein BE, Laties AM, Lewis M, Sharlip ID, Kolitsopoulos F, Klee BJ, Mo J, Reynolds RF. Campbell UB, et al. Among authors: laties am. J Sex Med. 2015 Jan;12(1):139-51. doi: 10.1111/jsm.12726. Epub 2014 Oct 31. J Sex Med. 2015. PMID: 25358826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters